NO934897L - Procedure for Preparing a Pharmaceutical Preparation - Google Patents

Procedure for Preparing a Pharmaceutical Preparation

Info

Publication number: NO934897L
Authority: NO; Norway
Prior art keywords: preparing; procedure; pharmaceutical preparation; pharmaceutical; preparation
Prior art date: 1986-08-20

Application number

NO934897A

Other languages

Norwegian (no)

Other versions

NO302176B1 (en

NO934897D0 (en

Inventor

Mary Kathleen Shriver

Elaine K Thomas

Wesley L Cosand

Larry H Gosting

Edna S Dickinson

Janela Mcclure

George J Todaro

Robert C Nowinski

Original Assignee

Genetic Systems Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-08-20

Filing date

1993-12-29

Publication date

1993-12-29

1993-12-29 Application filed by Genetic Systems Corp filed Critical Genetic Systems Corp

1993-12-29 Publication of NO934897L publication Critical patent/NO934897L/en

1993-12-29 Publication of NO934897D0 publication Critical patent/NO934897D0/en

1998-02-02 Publication of NO302176B1 publication Critical patent/NO302176B1/en

Classifications

- F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
- F04—POSITIVE - DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS FOR LIQUIDS OR ELASTIC FLUIDS
- F04B—POSITIVE-DISPLACEMENT MACHINES FOR LIQUIDS; PUMPS
- F04B25/00—Multi-stage pumps
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K16/1143—
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
- C12Q1/701—Specific hybridization probes
- C12Q1/702—Specific hybridization probes for retroviruses
- C12Q1/703—Viruses associated with AIDS
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
- C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2740/00—Reverse transcribing RNA viruses
- C12N2740/00011—Details
- C12N2740/10011—Retroviridae
- C12N2740/16011—Human Immunodeficiency Virus, HIV
- C12N2740/16211—Human Immunodeficiency Virus, HIV concerning HIV gagpol
- C12N2740/16222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Virology (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Immunology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Biophysics (AREA)
Genetics & Genomics (AREA)
Biochemistry (AREA)
Zoology (AREA)
AIDS & HIV (AREA)
Gastroenterology & Hepatology (AREA)
Biotechnology (AREA)
Microbiology (AREA)
Analytical Chemistry (AREA)
Physics & Mathematics (AREA)
Bioinformatics & Cheminformatics (AREA)
Medicinal Chemistry (AREA)
Mechanical Engineering (AREA)
Peptides Or Proteins (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)

NO934897A 1986-08-20 1993-12-29 Process for the preparation of a monoclonal antibody and an antigen NO302176B1 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date
US89827386A	1986-08-20	1986-08-20
US4502687A	1987-05-01	1987-05-01
US6799687A	1987-06-29	1987-06-29

Publications (3)

Publication Number	Publication Date
NO934897L true NO934897L (en)	1993-12-29
NO934897D0 NO934897D0 (en)	1993-12-29
NO302176B1 NO302176B1 (en)	1998-02-02

Family

ID=27366600

Family Applications (2)

Application Number	Title	Priority Date	Filing Date
NO873495A NO300462B1 (en)	1986-08-20	1987-08-19	Monoclonal antibodies and peptides that can be used to diagnose HIV infections
NO934897A NO302176B1 (en)	1986-08-20	1993-12-29	Process for the preparation of a monoclonal antibody and an antigen

Family Applications Before (1)

Application Number	Title	Priority Date	Filing Date
NO873495A NO300462B1 (en)	1986-08-20	1987-08-19	Monoclonal antibodies and peptides that can be used to diagnose HIV infections

Country Status (28)

Country	Link
JP (1)	JPS6485928A (en)
KR (1)	KR920008744B1 (en)
AT (1)	AT398080B (en)
AU (1)	AU616156B2 (en)
BE (1)	BE1000811A4 (en)
CH (1)	CH675728A5 (en)
CS (1)	CS275838B6 (en)
DE (1)	DE3727703A1 (en)
DK (1)	DK433087A (en)
ES (1)	ES2010727A6 (en)
FI (1)	FI873553A7 (en)
FR (1)	FR2603107B1 (en)
GB (1)	GB2196634B (en)
GR (1)	GR871298B (en)
HU (1)	HU214439B (en)
IE (1)	IE60671B1 (en)
IL (1)	IL83580A (en)
IT (1)	IT1222518B (en)
LU (1)	LU86972A1 (en)
NL (1)	NL8701950A (en)
NO (2)	NO300462B1 (en)
NZ (1)	NZ221440A (en)
OA (1)	OA08652A (en)
PL (1)	PL155084B1 (en)
PT (1)	PT85567B (en)
SE (1)	SE506025C2 (en)
YU (1)	YU152587A (en)
ZW (1)	ZW15487A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AP96A (en) *	1986-06-03	1990-08-12	The Usa Dept Of Commerce	Small peptides which inhibit binding to T-4 receptors and act as immunogens.
AU625720B2 (en) *	1987-05-01	1992-07-16	Genetic Systems Corporation	Monoclonal antibodies to specific antigenic regions of the human immunodeficiency virus and methods for use
US5834599A (en) *	1987-05-29	1998-11-10	Tanox Biosystems, Inc.	Immunoconjugates which neutralize HIV-1 infection
JP2520464B2 (en) *	1987-05-29	1996-07-31	タノツクス・バイオシステムズ・インコーポレーテツド	Monoclonal antibody that neutralizes HIV-1
US5981278A (en) *	1987-05-29	1999-11-09	Tanox, Inc.	Chimeric monoclonal antibodies which neutralize HIV-1 infection and their applications in therapy and prevention for AIDS
US6657050B1 (en)	1987-05-29	2003-12-02	Tanox, Inc.	Chimeric viral-neutralizing immunoglobulins
WO1989007112A1 (en) *	1988-01-26	1989-08-10	The United States Of America, As Represented By Th	A synthetic antigen evoking anti-hiv response
CA1341285C (en) *	1988-02-12	2001-08-14	Chang Yi Wang	Synthetic peptides for the detection of antibodies to hiv gp120 envelope protein for diagnosis of aids and pre-aids conditions and as vaccines
IL90048A0 (en) *	1988-04-25	1989-12-15	Merck & Co Inc	Recombinant gag precursor of hiv,its preparation and its use as aids vaccine
US5562905A (en) *	1988-04-26	1996-10-08	E. I. Du Pont De Nemours And Company	Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
EP0339504A3 (en) *	1988-04-26	1990-09-12	The Du Pont Merck Pharmaceutical Company	Human immunodeficiency virus (hiv) env-coded peptide capable of eliciting hiv-inhibiting antibodies in mammals
FR2632310B1 (en) *	1988-06-06	1992-04-10	Pasteur Institut	PEPTIDES HAVING PROTECTIVE PROPERTIES OF A PATHOGENIC VIRUS OF THE HIV TYPE IN SENSITIVE CELLS
AU640619B2 (en) *	1988-10-03	1993-09-02	Repligen Corporation	Hiv proteins and peptides useful in the diagnosis, prophylaxis or therapy of aids
CA2025481A1 (en) *	1989-09-19	1991-03-20	Peter J. Kniskern	Vaccine for aids and hepatitis b
SE9000333D0 (en) *	1990-01-31	1990-01-31	Britta Wahren	MONOCLONAL ANTIBODY
SE468168B (en) *	1990-02-20	1992-11-16	Replico Medical Ab	HIV-1, P24 PEPTIDES, DIAGNOSTIC ANTIGENS AND PROCEDURES FOR DIFFERENTIAL DIAGNOSTICS OF PRELIMINARY HIV-1 POSITIVE SERUM TESTS
JPH03271233A (en) *	1990-03-19	1991-12-03	Inst Pasteur	Induction of protection against viral infection by synergy between viral envelope glycoproteins and peptides corresponding to neutralizing epitopes of the glycoproteins
CA2047042A1 (en) *	1990-07-19	1992-01-20	John Hannah	Cyclic hiv principal neutralizing determinant peptides
CA2047078A1 (en) *	1990-07-19	1992-01-20	Steven S. Bondy	Cyclic hiv principal neutralizing determinant peptides
JPH05310785A (en) *	1991-09-30	1993-11-22	Nitto Denko Corp	Hiv-related cyclic peptide and adsorption material obtained by immobilizing the same
PT960886E (en) *	1992-03-27	2004-10-29	Advanced Immunit T Inc	PEPTIDE T AND RELATED PEPTIDES IN THE TREATMENT OF INFLAMMATION; INCLUDING MULTIPLE SCLEROSIS
ES2523858T3 (en)	2005-12-09	2014-12-02	Vectus Biosystems Limited	VIP fragments and compositions thereof
EP2323233B1 (en)	2008-09-02	2017-10-11	NGK Spark Plug Co., Ltd.	Spark plug
KR102727239B1 (en) *	2022-09-07	2024-11-07	한국세라믹기술원	Magnesium oxide powder and method for manufacturing the same

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US9328391B1 (en) *	1984-08-22	2016-05-03	The United States Of America As Represented By The Secretary, Department Of Health And Human Services	Cloning and expression of HIV-1 DNA
GB8501473D0 (en) *	1985-01-21	1985-02-20	Pasteur Institut	Cloned dna sequences
IE64006B1 (en) *	1984-10-18	1995-06-28	Pasteur Institut	Antigens particulary envelope antigens of the virus of lymphadenopathies and of the acquired immune-deficiency syndrome and virus process for producing virus envelope antigens use of said antigens in the preparation of immunogenic compositions or for the diagnosis of the presence of antibodies against this virus
CA1341482C (en) *	1984-10-31	2005-05-10	Paul A. Luciw	Process for preparing fragments of aids-associated retroviruses
IE64785B1 (en) *	1985-04-08	1995-09-06	Genetic Systems Corp	Expression of immunologically reactive viral proteins
EP0220234B1 (en) *	1985-04-08	1994-08-03	Genetic Systems Corporation	EXPRESSION AND DIAGNOSTIC USE OF gag ENCODED PEPTIDES WHICH ARE IMMUNOLOGICALLY REACTIVE WITH ANTIBODIES TO LAV
DK171119B1 (en) *	1985-04-19	1996-06-17	Hoffmann La Roche	AIDS virus envelope protein, expression vector carrying the envelope protein, transformants transformed with the expression vector, method of producing the virus envelope protein, method of detecting AIDS antibodies, method of determining AIDS virus, vaccine against AIDS, antibodies against the virus envelope protein and use of it to prepare a vaccine and for testing
ATE116006T1 (en) *	1985-04-29	1995-01-15	Genetic Systems Corp	SYNTHETIC ANTIGENS FOR DETECTING AIDS.
GB8525615D0 (en) *	1985-10-17	1985-11-20	Hoffmann La Roche	Polypeptides
DE3689941D1 (en) *	1985-10-24	1994-08-04	Southwest Found Biomed Res	SYNTHETIC PEPTIDES AND THEIR USE FOR DIAGNOSIS AND VACCINATION FOR AIDS AND ARC.
JP2837669B2 (en) *	1985-11-07	1998-12-16	プレジデントアンドフエロウズオブハ−バ−ドカレツジ	T-cell lymphotropic virus protein and its analysis
US4734362A (en) *	1986-02-03	1988-03-29	Cambridge Bioscience Corporation	Process for purifying recombinant proteins, and products thereof
US4772547A (en) *	1986-02-03	1988-09-20	Hoffmann-La Roche Inc.	HTLV-III envelope peptides
US4925784A (en) *	1986-04-04	1990-05-15	Hoffmann-La Roche Inc.	Expression and purification of an HTLV-III gag/env gene protein
DK169582B1 (en) *	1986-06-23	1994-12-12	Squibb Bristol Myers Co	Human monoclonal antibody capable of reacting with an epitope on the LAV / HTLV-III envelope glycoprotein gp41, cell lines producing such antibody, pharmaceutical preparation containing the antibody, and method for determining the presence of LAV / HTLV-III in a biological sample. and method for separating specific antigenic determinants of LAV / HTLV-III using ant
EP0255190A3 (en) *	1986-08-01	1990-08-29	Repligen Corporation	Recombinant polypeptides and their uses, inclusing assay for aids virus
AU592258B2 (en) *	1986-12-30	1990-01-04	United States of America, as represented by the Secretary, U.S. Department of Commerce, The	Synthetic peptides which induce cellular immunity to the aids virus and aids viral proteins

1987
- 1987-08-13 NZ NZ221440A patent/NZ221440A/en unknown
- 1987-08-14 ZW ZW154/87A patent/ZW15487A1/en unknown
- 1987-08-17 YU YU152587A patent/YU152587A/en unknown
- 1987-08-17 FI FI873553A patent/FI873553A7/en not_active Application Discontinuation
- 1987-08-18 IL IL83580A patent/IL83580A/en unknown
- 1987-08-18 ES ES8702431A patent/ES2010727A6/en not_active Expired
- 1987-08-19 GB GB8719587A patent/GB2196634B/en not_active Expired - Fee Related
- 1987-08-19 AU AU77201/87A patent/AU616156B2/en not_active Ceased
- 1987-08-19 KR KR1019870009058A patent/KR920008744B1/en not_active Expired
- 1987-08-19 FR FR878711736A patent/FR2603107B1/en not_active Expired - Fee Related
- 1987-08-19 SE SE8703225A patent/SE506025C2/en not_active IP Right Cessation
- 1987-08-19 NO NO873495A patent/NO300462B1/en unknown
- 1987-08-19 IE IE221987A patent/IE60671B1/en not_active IP Right Cessation
- 1987-08-19 LU LU86972A patent/LU86972A1/en unknown
- 1987-08-19 NL NL8701950A patent/NL8701950A/en not_active Application Discontinuation
- 1987-08-19 DE DE19873727703 patent/DE3727703A1/en not_active Withdrawn
- 1987-08-19 DK DK433087A patent/DK433087A/en not_active Application Discontinuation
- 1987-08-19 BE BE8700922A patent/BE1000811A4/en not_active IP Right Cessation
- 1987-08-19 IT IT21678/87A patent/IT1222518B/en active
- 1987-08-19 HU HU873707A patent/HU214439B/en not_active IP Right Cessation
- 1987-08-19 GR GR871298A patent/GR871298B/en unknown
- 1987-08-20 PT PT85567A patent/PT85567B/en not_active IP Right Cessation
- 1987-08-20 CH CH3210/87A patent/CH675728A5/de not_active IP Right Cessation
- 1987-08-20 AT AT0208987A patent/AT398080B/en not_active IP Right Cessation
- 1987-08-20 JP JP62207336A patent/JPS6485928A/en active Pending
- 1987-08-20 PL PL1987267401A patent/PL155084B1/en unknown
- 1987-08-20 CS CS876136A patent/CS275838B6/en unknown
- 1987-08-28 OA OA59183A patent/OA08652A/en unknown
1993
- 1993-12-29 NO NO934897A patent/NO302176B1/en unknown

Also Published As

Publication number	Publication date
ES2010727A6 (en)	1989-12-01
IL83580A (en)	1992-11-15
PL267401A1 (en)	1988-07-21
FI873553A0 (en)	1987-08-17
SE8703225D0 (en)	1987-08-19
DE3727703A1 (en)	1988-05-05
HU214439B (en)	1998-03-30
LU86972A1 (en)	1988-03-02
CS275838B6 (en)	1992-03-18
KR920008744B1 (en)	1992-10-09
KR890002547A (en)	1989-04-10
DK433087A (en)	1988-02-21
FI873553L (en)	1988-02-21
CH675728A5 (en)	1990-10-31
SE8703225L (en)	1988-02-21
PL155084B1 (en)	1991-10-31
FR2603107A1 (en)	1988-02-26
CS8706136A2 (en)	1990-08-14
GB8719587D0 (en)	1987-09-23
ATA208987A (en)	1994-01-15
AU616156B2 (en)	1991-10-24
IL83580A0 (en)	1988-01-31
NO873495D0 (en)	1987-08-19
BE1000811A4 (en)	1989-04-11
IT8721678A0 (en)	1987-08-19
GR871298B (en)	1988-01-12
AU7720187A (en)	1988-05-19
NL8701950A (en)	1988-03-16
YU152587A (en)	1992-09-07
NO302176B1 (en)	1998-02-02
JPS6485928A (en)	1989-03-30
PT85567A (en)	1987-09-01
FI873553A7 (en)	1988-02-21
NO300462B1 (en)	1997-06-02
GB2196634A (en)	1988-05-05
FR2603107B1 (en)	1992-04-24
HUT44619A (en)	1988-03-28
ZW15487A1 (en)	1988-09-14
IE872219L (en)	1988-02-20
IE60671B1 (en)	1994-08-10
NO873495L (en)	1988-02-22
NZ221440A (en)	1991-11-26
GB2196634B (en)	1991-05-15
OA08652A (en)	1988-11-30
DK433087D0 (en)	1987-08-19
SE506025C2 (en)	1997-11-03
NO934897D0 (en)	1993-12-29
PT85567B (en)	1991-02-08
IT1222518B (en)	1990-09-05
AT398080B (en)	1994-09-26

Publication	Publication Date	Title
NO882103D0 (en)	1988-05-13	PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION
NO173213C (en)	1993-11-17	PROCEDURE FOR PREPARING A PREPARATION INCLUDING A LIPOSOM
NO934897L (en)	1993-12-29	Procedure for Preparing a Pharmaceutical Preparation
NO885641D0 (en)	1988-12-20	PROCEDURE FOR PREPARING PHARMACEUTICAL PREPARATION.
NO880520L (en)	1988-08-10	PROCEDURE FOR PREPARING A CHOLESTYRAMINE PREPARATION
NO175286C (en)	1994-09-28	A process for the preparation of a pharmaceutical composition comprising double-walled microcapsules
NO903264L (en)	1991-01-29	PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION IN THE FORM OF MICROPARTICLES.
FI884636L (en)	1989-04-09	Method for preparing a long-acting pharmaceutical preparation
NO173486C (en)	1993-12-22	Procedure for Preparing a Pharmaceutical Preparation for Transdermal Drug Administration
FI894637A0 (en)	1989-09-29	A process for preparing a pharmaceutical formulation comprising a microemulsion
NO170516C (en)	1992-10-28	PROCEDURE FOR PREPARING A BECLOMETHASONDIPROPIONATE FORMULATION
NO892826L (en)	1990-01-12	PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION FOR AA PREVENT SEXUALLY TRANSFERABLE DISEASES.
FI892640A0 (en)	1989-05-31	A process for preparing a pharmaceutical composition comprising a piperidinoalkanol-ibuprofen combination
FI873106L (en)	1988-01-19	Method for preparing a sustained-release pharmaceutical preparation
NO172447C (en)	1993-07-21	PROCEDURE FOR B-AVERMECTIN PREPARATION
NO883054D0 (en)	1988-07-08	PROCEDURE FOR PREPARING PHARMACEUTICAL PREPARATIONS CONTAINING SOMATOSTATIN ANALOGS.
NO901232L (en)	1990-09-18	PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION
NO884052D0 (en)	1988-09-13	PROCEDURE FOR THE PREPARATION OF A THERAPEUTIC PREPARATION.
NO173590C (en)	1994-01-05	Process for the preparation of a stable nicorandil-containing pharmaceutical composition
NO870368D0 (en)	1987-01-29	PROCEDURE FOR PREPARING A PHARMACEUTICAL PREPARATION WITH LONG-TERM EFFECT.
NO870866L (en)	1987-09-07	METHOD FOR PREPARING A THERAPEUTIC COMBINATION PREPARATION.
FI884240L (en)	1989-03-18	Method for preparing a pharmaceutical preparation for topical use
NO177485C (en)	1995-09-27	Process for the preparation of a pharmaceutical inhalation preparation
NO171792C (en)	1993-05-05	PROCEDURE FOR THE PREPARATION OF A FREADICAL ADDITION POLYMER
NO171910C (en)	1993-05-19	PROCEDURE FOR PREPARING 1-ALKYL-5-NITROIMIDAZOLES